суббота, 26 ноября 2016 г.

Promising Alzheimer's drug fails in the last phase of clinical trials

Promising Alzheimer's drug fails in the last phase of clinical trials


A large trial of a drug to treat dementia caused by Alzheimer's disease has ended in failure after people receiving the treatment showed no significant improvements to those taking a placebo. The failure of the much anticipated drug, which showed promise in earlier results, is being seen as a disappointing setback, but not the end of hopes to fight the disease.



from Biotech News